Global Aortic Aneurysm Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Aortic Aneurysm Market is presumed to reach the market size of nearly USD 18.5 BN by 2030 from USD 6.1 BN in 2022 with a CAGR of 13.12% under the study period 2023-2030.

An aortic aneurysm refer to an abnormal bulge or swelling in the wall of the aorta, which is the largest artery in the body. This type of swelling can occur in any part of the aorta but are most commonly found in the abdominal and thoracic areas. Aortic aneurysms can be classified as either fusiform, which involves a gradual bulging of the aortic wall, or saccular, which involves a more localized bulging. Aneurysms can also be classified by size, with larger aneurysms posing a higher risk of rupture. Aortic aneurysms are often asymptomatic, which means that people may not know they have one until it is discovered during medical imaging tests for other reasons. However, in some cases, aneurysms can cause symptoms such as back pain, chest pain, abdominal pain, or shortness of breath.

Market Dynamics:

The prevalence of aortic aneurysms is increasing globally due to various factors such as the aging population, high blood pressure, obesity, smoking, and other lifestyle factors. This is driving the growth of the market. Advances in medical technologies are making it easier and safer to diagnose and treat aortic aneurysms. For example, minimally invasive surgical techniques such as endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) are becoming more widely available, making treatment more accessible to patients. The growing awareness about the risks and consequences of aortic aneurysms is driving demand for diagnosis and treatment. Increased public education campaigns about the condition are helping to raise awareness about the disease. The increase in healthcare expenditure by governments and private organizations is driving the growth of the aortic aneurysm market. This is due to the higher availability of funds for research and development and increasing investments by pharmaceutical and medical device companies to develop new treatment options. The growing geriatric population is a significant driver of the aortic aneurysm market. This demographic group is at higher risk for developing the disease, and their increasing numbers are contributing to the overall growth of the market. The incidence of co-morbid conditions such as diabetes and hypertension, which are linked to a higher risk of developing aortic aneurysms, is also driving the growth of the market. As the incidence of these conditions rises, so does the prevalence of aortic aneurysms.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of aortic aneurysm. The growth and trends of aortic aneurysm industry provide a holistic approach to this study.

Market Segmentation:

This section of the aortic aneurysm market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Thoracic Aortic Aneurysm (TAA)
Abdominal Aortic Aneurysm (AAA)

By Treatment

Open Surgical Repair (OSR)
Endovascular Aneurysm Repair (EVAR)

By Product

Stent Grafts
Catheters

By End User

Hospitals
Ambulatory Surgery Centers
Clinics

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Aortic Aneurysm market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the aortic aneurysm market include Medtronic, Endologix LLC, Gore Medical, MicroPort Scientific Corporation, Cook, JOTEC, Cardinal Health, Terumo Corporation, Lombard Medical, AbbVie Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112110482

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . AORTIC ANEURYSM - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Treatment
- 3.7.3 Market Attractiveness Analysis By Product
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL AORTIC ANEURYSM MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Thoracic Aortic Aneurysm (TAA) Historic and Forecast Sales by Regions
6.5 Abdominal Aortic Aneurysm (AAA) Historic and Forecast Sales by Regions

7 . GLOBAL AORTIC ANEURYSM MARKET ANALYSIS BY TREATMENT

7.1 Overview by Treatment
7.2 Historical and Forecast Data
7.3 Analysis by Treatment
7.4 Open Surgical Repair (OSR) Historic and Forecast Sales by Regions
7.5 Endovascular Aneurysm Repair (EVAR) Historic and Forecast Sales by Regions

8 . GLOBAL AORTIC ANEURYSM MARKET ANALYSIS BY PRODUCT

8.1 Overview by Product
8.2 Historical and Forecast Data
8.3 Analysis by Product
8.4 Stent Grafts Historic and Forecast Sales by Regions
8.5 Catheters Historic and Forecast Sales by Regions

9 . GLOBAL AORTIC ANEURYSM MARKET ANALYSIS BY END USER

9.1 Overview by End User
9.2 Historical and Forecast Data
9.3 Analysis by End User
9.4 Hospitals Historic and Forecast Sales by Regions
9.5 Ambulatory Surgery Centers Historic and Forecast Sales by Regions
9.6 Clinics Historic and Forecast Sales by Regions

10 . GLOBAL AORTIC ANEURYSM MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE AORTIC ANEURYSM COMPANIES

11.1. Aortic Aneurysm Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF AORTIC ANEURYSM INDUSTRY

12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. Medtronic
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Endologix LLC
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Gore Medical
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. MicroPort Scientific Corporation
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Cook
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. JOTEC
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Cardinal Health
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Terumo Corporation
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Lombard Medical
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. AbbVie Inc.
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies